Background-Repolarization abnormalities in the inferior-lateral leads in Brugada syndrome (BS) have not been systematically investigated. Methods and Results-280 patients (age, 41Ϯ18 years; 168 males) with BS were screened for inferior-lateral repolarization abnormalities. The repolarization abnormalities were classified either as early repolarization pattern or coved Ն2-mm Brugada pattern and as spontaneous or class I antiarrhythmic drug (AAD) induced. Thirty-two patients (11%) had inferior-lateral spontaneous early repolarization pattern. These patients were less likely to be asymptomatic at first presentation (13 of 32 versus 156 of 248 patients, Pϭ0.02), and spontaneous type I ECG was more frequent among them (38% versus 21%, Pϭ0.05). The spontaneous early repolarization pattern occurred more frequently among patients with BS than in 283 family members not having BS (11% versus 6%, Pϭ0.03). Class I AAD administration provoked inferior-lateral coved Brugada pattern in 13 patients with BS. These patients had longer baseline PR intervals (206Ϯ48 versus 172Ϯ31 ms, PϽ0.001) and class I AAD-induced QRS interval prolongation (108 to 178 versus 102 ms to 131 ms, PϽ0.001). In 3 patients, the class I AAD-provoked coved Brugada pattern was only present in the inferior leads. Conclusions-Inferior-lateral early repolarization pattern occurs spontaneously relatively frequently in BS. These patients have a more severe phenotype. Class I AAD administration provokes inferior-lateral coved Brugada pattern in 4.6% of patients. We report for the first time 3 patients in whom the class I AAD-provoked coved Brugada pattern was only observed in the inferior leads. (Circ Arrhythmia Electrophysiol. 2009;2:154-161.)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.